Top Markets
#1 Nesa Nesa +22.94%
#2 MetaDAO MetaDAO +17.37%
#3 Tornado Cash Tornado Cash +8.86%
#4 Utya Utya +8.67%
#5 Cash Cat Cash Cat +7.88%
#6 Arowana Arowana +7.43%
#7 Solstice Solstice +7.00%
#8 Raydium Raydium +5.97%
#9 Pons Pons +5.94%
#10 Ontology Gas Ontology Gas +5.78%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Sandoz Group AG Sandoz Group AG

Sandoz Group AG

SDZ
Rank in Stocks #622
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Share Price
$95.44
Last synced: 2026-08-24
Market Cap
$41.29B
Change (1 day)
-0.62%
Change (1 year)
52.20%
Country
CH
Trade Sandoz Group AG (SDZ)

Category

Healthcare
P/E ratio for Sandoz Group AG (SDZ)
P/E ratio as of 2026 TTM: 0
According to Sandoz Group AG latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Sandoz Group AG from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.